InvestSMART

Control Bionics Limited (ASX: CBL) - Announcements

- Current share price for CBL : $0.060

ASX company news and announcements for Control Bionics Limited (CBL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Control Bionics Limited (CBL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Control Bionics Limited (CBL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Control Bionics Limited (CBL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$33 Chairman's Address to Shareholders 3 May 2017 7:37AM $3.220 $0.060 fallen by 98.14%
$33 Results of Meeting 3 May 2017 12:26AM $3.210 $0.060 fallen by 98.13%
$33 Notice of General Meeting/Proxy Form 13 Apr 2017 10:34AM $3.200 $0.060 fallen by 98.13%
$33 Notice of General Meeting/Proxy Form 13 Apr 2017 10:34AM $3.200 $0.060 fallen by 98.13%
$33 CBL Share Sell-down Process Completed 5 Apr 2017 10:28AM $3.200 $0.060 fallen by 98.13%
$33 Ongoing Disclosure Notice 5 Apr 2017 7:32AM $3.350 $0.060 fallen by 98.21%
$33 SSH Notice - Alistair Leighton Hutchison 5 Apr 2017 7:32AM $3.350 $0.060 fallen by 98.21%
$33 SSH Notice - Peter Alan Harris & Oceanic Securities Pte Ltd 5 Apr 2017 7:32AM $3.350 $0.060 fallen by 98.21%
$33 CBL Share Sell-Down To Increase Share Market Liquidity 5 Apr 2017 7:31AM $3.350 $0.060 fallen by 98.21%
$33 Section 209 31 Mar 2017 8:32AM $3.120 $0.060 fallen by 98.08%
$33 Annual Report to shareholders 31 Mar 2017 8:31AM $3.120 $0.060 fallen by 98.08%
$33 Update - Dividend/Distribution - CBL 27 Mar 2017 1:10PM $3.110 $0.060 fallen by 98.07%
$33 CBL ANNOUNCES CONDITIONAL AGREEMENT TO BUY US INSURER 24 Mar 2017 1:18PM $3.090 $0.060 fallen by 98.06%
$33 S&P DJ Indices Announces March Quarterly Rebalance 10 Mar 2017 8:19AM $3.000 $0.060 fallen by 98%
$33 CBL Supplementary Information for the 2016 Annual Result 1 Mar 2017 7:32AM $2.780 $0.060 fallen by 97.84%
$33 Ongoing Disclosure Notice 1 Mar 2017 12:38AM $2.700 $0.060 fallen by 97.78%
$33 Ongoing Disclosure Notice 1 Mar 2017 12:37AM $2.700 $0.060 fallen by 97.78%
$33 Dividend/Distribution - CBL 24 Feb 2017 8:38AM $3.450 $0.060 fallen by 98.26%
$33 CBL 2016 Results Presentation 24 Feb 2017 8:38AM $3.450 $0.060 fallen by 98.26%
$33 CBL 2016 Financial Report 24 Feb 2017 8:37AM $3.450 $0.060 fallen by 98.26%
$33 CBL Results Presentation 24 Feb 2017 8:34AM $3.450 $0.060 fallen by 98.26%
$33 Focused and consistent strategy sees CBL beat forecasts 24 Feb 2017 8:33AM $3.450 $0.060 fallen by 98.26%
$33 FY16 Full Year Results Announcement Date 24 Jan 2017 2:35PM $3.510 $0.060 fallen by 98.29%
$33 CBL CORPORATION CLOSES NZ$150M STRATEGIC ACQUISITION 6 Jan 2017 8:09AM $3.470 $0.060 fallen by 98.27%
$33 CBL has no exposure to earthquake 14 Nov 2016 7:42AM $3.350 $0.060 fallen by 98.21%

501 - 525 of 626 results

Page 21 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.